Exclusive: Takeda to win EU approval for $62 billion Shire deal – sources

Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its $62-billion (47.7 billion pounds) bid for London’s Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday.

Source: Reuters Feed

(Visited 1 times, 1 visits today)

RSS Feed

Just a chill little widget delivery boy. =)

Leave a Reply

Your email address will not be published. Required fields are marked *